Pfizer and Moderna to expand size of vaccine studies in 5- to 11-year-olds
(LOS ANGELES) — Pfizer and Moderna are expanding the size of their COVID-19 vaccine studies in children ages 5 to 11, according to a new report.The decision, which came after a push from the Food and Drug Administration, according to The New York... Read More.